Abnormal expression of the IBSP gene is closely associated with bone metastasis, an increased risk of malignancy and poor prognosis in patients with breast cancer, prostate cancer and non-small-cell lung cancer (Gordon et al., 2009; Wang et al., 2019; Wu et al., 2021). Here, IBSP is linked to prostate carcinoma.